Dexcom (DXCM) Other Non-Current Assets (2010 - 2026)
Dexcom (DXCM) reported Other Non-Current Assets of $285.9 million for Q1 2026, up 69.67% year-over-year from $168.5 million in Q1 2025, and up 2.58% quarter-over-quarter from $278.7 million in Q4 2025.
Dexcom (DXCM) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has 17 years of Other Non-Current Assets data on file, last reported at $285.9 million in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $285.9 million, up 69.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $285.9 million (up 69.67% YoY), and the FY2025 annual result was $278.7 million, up 61.1% from the prior year.
- Other Non-Current Assets improved to $285.9 million in Q1 2026 per DXCM's latest filing, from $278.7 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $285.9 million in Q1 2026 and troughed at $22.8 million in Q1 2022.
- A 5-year average of $118.1 million and a median of $77.7 million in 2024 frame the typical range for Other Non-Current Assets.
- On a YoY basis, Other Non-Current Assets climbed as much as 348.57% in 2022 and fell as far as 6.44% in 2022.
- A 5-year view of Other Non-Current Assets shows it stood at $47.1 million in 2022, then soared by 59.24% to $75.0 million in 2023, then surged by 130.67% to $173.0 million in 2024, then jumped by 61.1% to $278.7 million in 2025, then grew by 2.58% to $285.9 million in 2026.
- Business Quant data shows DXCM's Other Non-Current Assets at $285.9 million in Q1 2026, $278.7 million in Q4 2025, and $276.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 828.89 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 1.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 285.90 Mn |
| Dec 31, 2025 | 278.70 Mn |
| Sep 30, 2025 | 276.50 Mn |
| Jun 30, 2025 | 175.50 Mn |
| Mar 31, 2025 | 168.50 Mn |
| Dec 31, 2024 | 173.00 Mn |
| Sep 30, 2024 | 88.20 Mn |
| Jun 30, 2024 | 82.90 Mn |
| Mar 31, 2024 | 77.70 Mn |
| Dec 31, 2023 | 75.00 Mn |
| Sep 30, 2023 | 74.40 Mn |
| Jun 30, 2023 | 66.90 Mn |
| Mar 31, 2023 | 56.60 Mn |
| Dec 31, 2022 | 47.10 Mn |
| Sep 30, 2022 | 33.70 Mn |
| Jun 30, 2022 | 24.80 Mn |
| Mar 31, 2022 | 22.80 Mn |
| Dec 31, 2021 | 10.50 Mn |
| Jun 30, 2021 | 23.30 Mn |
| Mar 31, 2021 | 20.40 Mn |